Literature DB >> 3362861

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

B Newman1, M A Austin, M Lee, M C King.   

Abstract

Segregation analysis of breast cancer in families can provide the logical basis and the specific genetic models for mapping and identifying genes responsible for human breast cancer. Patterns of breast cancer occurrence in families were investigated by complex segregation analysis. In a sample of 1579 nuclear families ascertained through a population-based series of probands, an autosomal dominant model with a highly penetrant susceptibility allele fully explained disease clustering. From the maximum-likelihood Mendelian model, the frequency of the susceptibility allele was 0.0006 in the general population, and lifetime risk of breast cancer was 0.82 among susceptible women and 0.08 among women without the susceptibility allele. Inherited susceptibility affected only 4% of families in the sample: multiple cases of this relatively common disease occurred in other families by chance. The same genetic models, with higher gene frequency, explained disease clustering in an extended kindred at high risk of breast cancer. Evidence for a highly penetrant, autosomal dominant susceptibility allele for breast cancer in a high-risk family and the general population suggests that high-risk families can serve as models for understanding breast cancer in the population as a whole.

Entities:  

Mesh:

Year:  1988        PMID: 3362861      PMCID: PMC280139          DOI: 10.1073/pnas.85.9.3044

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A unified model for complex segregation analysis.

Authors:  J M Lalouel; D C Rao; N E Morton; R C Elston
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

2.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

3.  Cancer incidence and mortality in the United States, 1973-77.

Authors:  J L Young; C L Percy; A J Asire; J W Berg; M M Cusano; L A Gloeckler; J W Horm; W I Lourie; E S Pollack; E M Shambaugh
Journal:  Natl Cancer Inst Monogr       Date:  1981-06

4.  Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13.

Authors:  U Francke; L B Holmes; L Atkins; V M Riccardi
Journal:  Cytogenet Cell Genet       Date:  1979

5.  Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.

Authors:  R C Go; M C King; J Bailey-Wilson; R C Elston; H T Lynch
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

6.  Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.

Authors:  A Koufos; M F Hansen; B C Lampkin; M L Workman; N G Copeland; N A Jenkins; W K Cavenee
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

7.  Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D.

Authors:  R S Sparkes; A L Murphree; R W Lingua; M C Sparkes; L L Field; S J Funderburk; W F Benedict
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

8.  Epidemiology of breast carcinoma III: relationship of family history to tumor type.

Authors:  P P Rosen; M L Lesser; R T Senie; D W Kinne
Journal:  Cancer       Date:  1982-07-01       Impact factor: 6.860

9.  Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.

Authors:  F R Berberich; M S Berberich; M C King; E G Engleman; F C Grumet
Journal:  Hum Immunol       Date:  1983-04       Impact factor: 2.850

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  120 in total

1.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

2.  Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

3.  Family History of Breast Cancer and Breast Cancer Risk in Japan.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

Review 4.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

5.  Interactions between genetic and reproductive factors in breast cancer risk in a French family sample.

Authors:  N Andrieu; F Demenais
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

6.  BRCA1 variants in a family study of African-American and Latina women.

Authors:  Roberta McKean-Cowdin; Heather Spencer Feigelson; Lucy Y Xia; Celeste Leigh Pearce; Duncan C Thomas; Daniel O Stram; Brian E Henderson
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

7.  BayesMendel: an R environment for Mendelian risk prediction.

Authors:  Sining Chen; Wenyi Wang; Karl W Broman; Hormuzd A Katki; Giovanni Parmigiani
Journal:  Stat Appl Genet Mol Biol       Date:  2004-09-17

8.  Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.

Authors:  E M Rakowicz-Szulczynska; B Jackson; A M Szulczynska; M Smith
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 9.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

10.  The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.

Authors:  B Newman; P G Moorman; R Millikan; B F Qaqish; J Geradts; T E Aldrich; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.